Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: BEACON - ABC in Recurrent Platinum Resistant HGSOC [Phase 2]
Phase 2 trial update for BEACON program in recurrent platinum-resistant high-grade serous ovarian cancer (HGSOC).
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update of veliparib combined with topotecan hydrochloride in adults with solid tumors, relapsed or refractory ovarian cancer,…
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy [Phase 3]
A Phase 3 trial evaluating high-dose inorganic selenium for preventing chemotherapy-induced peripheral neuropathy in ovarian cancer patients…
-
FDA approval · 2023-05-31FDA Approved: LYNPARZA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for LYNPARZA (olaparib) from AstraZeneca Pharmaceuticals LP, resulting in changes to the product…
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Oregovomab and PLD in PARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum Retreatment [Phase 2]
A Phase 2 clinical trial investigating oregovomab and pegylated liposomal doxorubicin (PLD) in patients with PARP inhibitor–resistant ovaria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208) [Phase 2]
Phase 2 safety-run-in update for weekly tisotumab vedotin in platinum-resistant ovarian cancer (innovaTV 208) completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer [Phase 2]
Phase 2 trial evaluating ALT-803 administered subcutaneously after initial ALT-803 treatment for ovarian cancer, fallopian tube cancer, and …
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies [Phase 2]
Phase 2 trial update for enzalutamide in AR-positive ovarian, fallopian tube, or primary peritoneal cancer completed with results posted.
-
FDA approval · 2023-04-26FDA Approved: ZEJULA — Original Application (GlaxoSmithKline LLC)
FDA approved ZEJULA (niraparib) in an original application submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2023-04-21Clinical Trial Update: Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating cyclophosphamide with or without celecoxib in recurrent/persistent ovarian epithelial, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial update on the combination of cediranib and olaparib for recurrent cancers of the fallopian tube, ovary, or peritoneum…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer [Phase 2]
Phase 2 trial update of olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, fallopian tube, and primary periton…
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]
Phase 2 trial update evaluating pembrolizumab in combination with chemotherapy as frontline treatment for advanced ovarian, primary peritone…
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
This Phase 3 trial evaluated bevacizumab in addition to standard therapy for newly diagnosed Stage III/IV epithelial ovarian, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing atezolizumab plus paclitaxel, carboplatin, and bevacizumab versus control in newly diagnosed ovarian, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients [Phase 2]
A Phase 2 clinical trial update on heated intraperitoneal chemotherapy for ovarian cancer, with unclear status.
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab after weekly paclitaxel in platinum-resistant ovarian, fallopian tube, or peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer [Phase 1, Phase 2]
Clinical trial update for GL-ONC1 oncolytic immunotherapy in recurrent or refractory ovarian cancer (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Bevacizumab Plus Modiifed FOLFIRINOX in Ovarian, Fallopian Tube, or Primary Peritoneal Mucinous Carcinoma [Phase 2]
Phase 2 clinical trial evaluating bevacizumab with modified FOLFIRINOX for mucinous ovarian, fallopian tube, or primary peritoneal cancers.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer [Phase 3]
A single-arm Phase 3 trial of IMGN853 in Chinese adults with platinum-resistant epithelial ovarian cancer is ongoing, with conditions includ…
-
FDA approval · 2022-11-14FDA Approved: ELAHERE — Original Application (ImmunoGen, Inc.)
The FDA approved ELAHERE (mirvetuximab soravtansine) from ImmunoGen as the original approval for FRα-positive, platinum-resistant epithelial…
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine hydrochloride alone or in combination with M6620 for recurrent ovarian, fallopian tube, or pri…
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation [Phase 2]
Phase 2 trial evaluating the combination of olaparib, durvalumab, and tremelimumab in patients with BRCA1/BRCA2-mutated recurrent or refract…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab [NA]
Clinical trial assessing perfusion CT to predict outcomes in ovarian, fallopian tube, or peritoneal cancer treated with bevacizumab; the stu…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating a vaccine therapy with paclitaxel and carboplatin in patients undergoing surgery for advanced ovarian cancer, prima…